GST Updates: Lower Rates on Cancer Drugs & Snacks, New Reverse Charge, E-Invoicing Pilot, and Tax Waivers Proposed.
News
GST
GST Council recommends formation of Group of Ministers to study GST on life and health insurance, and future of compensation cess. Exemption recommended for research and development services by government entities, universities using government or private grants. GST rates reduced from 12% to 5% on cancer drugs Trastuzumab Deruxtecan, Osimertinib and Durvalumab. G
= = = = = = = =
Plain text (Extract) only
For full text:-Visit the Source
= = = = = = = =